Bayesian Capital Management, LP Dexcom Inc Transaction History

Bayesian Capital Management, LP

$838 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $617,736 - $786,519	5,600 New	5,600 $634,000
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $1.51 Million - $2.48 Million	20,000 Added 58.76%	54,036 $6.71 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $2.08 Million - $3.34 Million	24,200 Added 246.03%	34,036 $3.18 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $1.11 Million - $1.29 Million	9,836 New	9,836 $1.26 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $714,086 - $1.03 Million	8,403 New	8,403 $951,000
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $366,466 - $716,277	5,390 Added 334.78%	7,000 $522,000
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $151,468 - $209,621	1,610 New	1,610 $824,000
Q1 2021 May 14, 2021	SELL	$84.79 - $104.74 $551,135 - $680,810	-6,500 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$78.0 - $104.5 $33,540 - $44,935	430 Added 7.08%	6,500 $2.4 Million
Q3 2020 Nov 12, 2020	SELL	$95.51 - $112.95 $515,754 - $609,930	-5,400 Reduced 47.08%	6,070 $2.5 Million
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $150,432 - $252,816	-2,400 Reduced 17.3%	11,470 $4.65 Million
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $52,569 - $83,193	1,100 Added 8.61%	13,870 $3.74 Million
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $467,637 - $731,593	12,770 New	12,770 $2.79 Million
Q3 2019 Nov 13, 2019	SELL	$35.53 - $43.8 $177,650 - $219,000	-5,000 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$27.84 - $38.92 $201,645 - $281,897	-7,243 Reduced 59.16%	5,000 $749,000
Q1 2019 May 14, 2019	SELL	$28.07 - $38.18 $274,945 - $373,973	-9,795 Reduced 44.45%	12,243 $1.46 Million
Q4 2018 Feb 13, 2019	SELL	$26.99 - $37.37 $89,067 - $123,320	-3,300 Reduced 13.02%	22,038 $2.64 Million
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $402,507 - $632,979	17,238 Added 212.81%	25,338 $3.62 Million
Q2 2018 Aug 14, 2018	BUY	$17.54 - $25.22 $142,074 - $204,282	8,100 New	8,100 $769,000
Q1 2018 May 15, 2018	SELL	$13.06 - $18.54 $347,722 - $493,627	-26,625 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$11.12 - $15.38 $47,538 - $65,749	-4,275 Reduced 13.83%	26,625 $1.53 Million
Q3 2017 Nov 14, 2017	BUY	$11.36 - $18.98 $351,024 - $586,482	30,900	30,900 $1.51 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Account